Summary of RAPTOR PHARMACEUTICAL CORP

Item 2.02 Results of Operations and Financial Condition.
On November 14, 2012, Raptor Pharmaceutical Corp., a Delaware corporation (the "Company"), issued a press release reporting its financial results for its fourth quarter and fiscal year ended August 31, 2012. A copy of the press release is being furnished as Exhibit 99.1 and is incorporated herein by reference.
The information included in this Item 2.02 of this Current Report on Form 8-K, including the information incorporated by reference in the exhibit hereto, shall not be deemed "filed" for purposes of, nor shall it be deemed incorporated by reference in, any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits

(d)      Exhibits.
                            Filed
Exhibit                     Here                 Incorporated by Reference
  No.   Exhibit Description with   Form  File No.  Exhibit Filing Date      Filed By
 99.1   Press release         X
        issued by the
        Company dated as of
        November 14, 2012